Search
Amelenodor
go.drugbank.com/drugs/DB21563ExperimentalAmelenodor is a small molecule drug. Amelenodor has a monoisotopic molecular weight of 399.16 Da.
Vulolisib
go.drugbank.com/drugs/DB21567ExperimentalVulolisib is a small molecule drug. Vulolisib has a monoisotopic molecular weight of 423.12 Da.
Teprosulvose
go.drugbank.com/drugs/DB21738ExperimentalTeprosulvose is a small molecule drug. Teprosulvose has a monoisotopic molecular weight of 568.33 Da.
Suvadronabinol
go.drugbank.com/drugs/DB21741ExperimentalSuvadronabinol is a small molecule drug. Suvadronabinol has a monoisotopic molecular weight of 513.31 Da.
Lurbinectedin
go.drugbank.com/drugs/DB12674ApprovedInvestigationalthe substitution of the tetrahydroisoquinoline with a tetrahydro β‐carboline that results in increased antitumour activity of lurbinectedin as compared to its predecessor. … Lurbinectedin is a DNA alkylating agent that has been investigated in the treatment of a variety of cancers, including mesothelioma,[A214325] chronic lymphocytic leukemia (CLL),[A214328] breast cancer,
Levobetaxolol
go.drugbank.com/drugs/DB09351ApprovedLevobetaxolol is a beta-blocker used to lower the pressure in the eye to treat conditions such as glaucoma. … It was marketed as a 0.5% ophthalmic solution of levobetaxolol hydrochloride under the trade name Betaxon but has been discontinued.
Mecobalamin
go.drugbank.com/drugs/DB03614ApprovedInvestigationalMixtures: L-Methyl PNV DHA, Levomefolate Calcium, Pyridoxal 5-phosphate, Methylcobalamin and Schizochytrium DHA OilCategories: Vitamin B ComplexDyphylline
go.drugbank.com/drugs/DB00651ApprovedWithdrawnDyphylline is a theophylline derivative with broncho- and vasodilator properties. It is typically used in the management of asthma, cardiac dyspnea, and bronchitis.
Mixtures: Dy G, ESPEKTAN A ŞURUP, 100 MLInavolisib
go.drugbank.com/drugs/DB15275ApprovedInvestigational_PIK3CA_ is one of the most frequently mutated oncogenes, with the resulting mutated p110α protein it encodes playing a central role in tumor cell proliferation. … Inavolisib is an inhibitor of PI3Kα that was approved by the FDA in October 2024 for the treatment of certain patients with advanced breast cancers.
Synonyms: (2S)-2-((2-((4S)-4-(difluoromethyl)-2-oxo-3-oxazolidinyl)-5,6-dihydroimidazo(1,2-D)(1,4)benzoxazepin-9-yl)amino)propanamide, propanamide, 2-((2-((4S)-4-(difluoromethyl)-2-oxo-3-oxazolidinyl)-5,6-dihydroimidazo(1,2-D)(1,4)benzoxazepin-9-yl)amino)-, (2S)-Lime (citrus)
go.drugbank.com/drugs/DB10635ApprovedLime (citrus) allergenic extract is used in allergenic testing.
Mixtures: Dr. SEED Teatree and Lime Vegan No-sebum Cool Anti HairlossShampoo